Top 50 Medical Startup Investors in Germany (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
22 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $994k–$40M |
|
Bayern Kapital
VC Fund
|
14 | Germany, United States, Finland | Seed, Series A | Software, Health Care, Information Technology | $1.1M–$31M |
|
KfW
VC Fund
|
11 | Germany, India, Spain | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
BioMedPartners
VC Fund
|
8 | Switzerland, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.9M–$83M |
|
NRW.BANK
VC Fund
|
7 | Germany, United States, France | Seed, Series A, Series B | Information Technology, Software, Biotechnology | $219k–$71M |
|
MIG Capital
VC Fund
|
7 | Germany, France, Austria | Series A, Series B | Biotechnology, Health Care, Therapeutics | $1.6M–$54M |
|
Calm/Storm VC
VC Fund
|
7 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $478k–$18M |
|
TGFS - Technologiegründerfonds Sachsen
VC Fund
|
6 | Germany, United States | Seed, Series A | Software, Information Technology, Manufacturing | $932k–$15M |
|
Wellington Partners
VC Fund
|
6 | Germany, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $3.1M–$55M |
|
Brandenburg Kapital
VC Fund
|
6 | Germany, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $823k–$14M |
|
b2venture
VC Fund
|
6 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.3M–$52M |
|
HV Capital
VC Fund
|
5 | Germany, United Kingdom, United States | Series A, Seed, Series B | E-Commerce, Software, Internet | $1.5M–$80M |
|
Heal Capital
VC Fund
|
5 | Germany, United Kingdom, France | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Machine Learning | $1M–$33M |
|
Possible Ventures
VC Fund
|
5 | Germany, Australia, United States | Seed, Pre-Seed, Series A | Software, Biotechnology, Information Technology | $549k–$44M |
|
IBB Ventures
VC Fund
|
5 | Germany, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $1M–$9M |
|
Rheingau Founders
VC Fund
|
5 | Germany, United States, Poland | Seed, Series A, Pre-Seed | Software, E-Commerce, Internet | $110k–$14M |
|
Picus Capital
VC Fund
|
5 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Financial Services, Software, FinTech | $549k–$33M |
|
Atlantic
VC Fund
|
5 | Germany, Switzerland, United States | Seed, Series A, Pre-Seed | Software, Health Care, Financial Services | $850k–$32M |
|
bm-t beteiligungsmanagement thuringen
VC Fund
|
5 | Germany, United States | Seed, Series A | Software, Information Technology, Health Care | $461k–$18M |
|
DvH Ventures
VC Fund
|
4 | Germany, Austria, United Kingdom | Seed, Series A | Health Care, Software, Financial Services | $1M–$31M |
|
YZR Capital
VC Fund
|
4 | Germany, Poland, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical, Software | $764k–$48M |
|
Maximilian Tayenthal
Angel
|
4 | Germany, United Kingdom, Spain | Seed, Pre-Seed, Series A | FinTech, Financial Services, Software | $202k–$15M |
|
KHAN Technology Transfer Fund
VC Fund
|
4 | Germany, Austria, Luxembourg | Seed, Series A, Venture - Series Unknown | Biotechnology, Medical, Biopharma | $259k–$11M |
|
Vorwerk Ventures
VC Fund
|
4 | Germany, United Kingdom, Denmark | Seed, Series A, Series B | E-Commerce, Health Care, Software | $3.3M–$88M |
|
EQT Life Sciences
VC Fund
|
4 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.9M–$165M |
|
seed + speed Ventures
VC Fund
|
4 | Germany, Austria, Switzerland | Seed, Pre-Seed, Series A | Software, SaaS, Artificial Intelligence | $603k–$20M |
|
Feliks Eyser
Angel
|
3 | Germany | Seed, Series A | Software, E-Learning, Medical | $3.2M–$27M |
|
SOSV
VC Fund
|
3 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Springboard Health Angels
VC Fund
|
3 | Germany, United States, Sweden | Seed, Pre-Seed | Health Care, Software, Medical | |
|
BayBG Venture Capital
VC Fund
|
3 | Germany, Italy, United States | Series A, Series B | Software, Information Technology, Health Care | $428k–$23M |
|
Bertelsmann Investments
VC Fund
|
3 | Germany, United States, Israel | Series A, Seed, Series B | Health Care, Medical, Artificial Intelligence | $3M–$33M |
|
UNIQA Ventures
VC Fund
|
3 | Austria, Germany, United Kingdom | Series A, Seed, Series B | FinTech, Insurance, Health Care | $439k–$125M |
|
Global Asset Fund
VC Fund
|
3 | Germany | Series A, Series B | Medical, Therapeutics, Biotechnology | $1M–$2.9M |
|
Sparkasse Jena
VC Fund
|
3 | Germany, United States | Seed, Series A, Series C | Medical, Health Care, Shopping | |
|
Super Angels
VC Fund
|
3 | Germany, United States, India | Seed, Pre-Seed | Software, Artificial Intelligence, SaaS | $250k–$3.5M |
|
Speedinvest
VC Fund
|
3 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $549k–$38M |
|
Forbion Capital Partners
VC Fund
|
3 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $15M–$176M |
|
IFB Innovationsstarter
VC Fund
|
3 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $80k–$3M |
|
Playground Global
VC Fund
|
3 | United States, Canada, Italy | Series A, Series B, Seed | Software, Robotics, Biotechnology | $2.2M–$153M |
|
Capacura
VC Fund
|
3 | Germany | Seed, Pre-Seed | Health Care, Recycling, Medical | $250k–$1.6M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
|
WestTech Ventures
VC Fund
|
3 | Germany, United States, France | Seed, Series A | Software, Internet, Information Technology | $1M–$12M |
|
Diana zur Löwen
Angel
|
3 | Germany, Switzerland | Pre-Seed, Seed, Debt Financing | Software, FinTech, Financial Services | $3.6M–$4.4M |
|
Born2Grow
VC Fund
|
3 | Germany, Finland, United States | Seed, Series A, Series B | Software, Medical, Health Care | $1.1M–$3.3M |
|
VI Partners
VC Fund
|
3 | Switzerland, Germany, United States | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.3M–$41M |
|
Verena Pausder
Angel
|
3 | Germany, United States, United Kingdom | Seed, Pre-Seed, Series A | Food and Beverage, E-Learning, EdTech | $1k–$18M |
|
Gloria Baeuerlein
Angel
|
3 | Germany, Sweden, Denmark | Seed, Pre-Seed, Series A | FinTech, Information Technology, B2B | $531k–$12M |
|
LSP BioVentures
VC Fund
|
3 | United States, Germany, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $5.3M–$176M |
|
Vesalius Biocapital Partners
VC Fund
|
3 | Belgium, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$100M |
|
Mario Götze
Angel
|
3 | Germany, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, SaaS, Information Technology | |
| Access all 597 investors in Germany Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 557
- Round size: Seed $994k–$7.4M; Series A $3M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- QphoX — QphoX builds quantum modem device, connecting quantum computers across a quantum network.
- Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
- BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States, Finland
Investor stats
- Total investments: 235
- Round size: Seed $1.1M–$5.9M; Series A $3.9M–$31M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $26M in 2010
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- ProGlove — ProGlove makes award-winning wearable wireless barcode scanners using BLE or RF technology for ergonomic and efficient hands-free workflows.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, Spain
Investor stats
- Total investments: 143
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- GermanSubCo — Vulcan Energie Ressourcen GmbH ("GermanSubCo") is the primary German holding subsidiary of Vulcan Energy Resources. It focused on lithium extraction combined with geothermal renewable energy production in the Upper Rhine Valley.
- Power Finance Corporation — Power Finance provides financial products and related advisory, and other services to the power sector in India. It offers fund based financial policies/products, including asset acquisition; bridge, corporate, short term, and rupee and foreign currency term loans; short term loan for SPV; buyer’s line of credit; and credit facility forpurchase of power. Power Finance's fund based financial policies/products also include debt refinancing; energy saving projects; fuel supply projects and equipment manufacturers financing; grants/interest free loans for studies/consultancies; lease financing for wind power projects and purchase of equipment; line of credit for import of coal; takeout financing; and solar PV policy to private sector. Its non-fund based products comprise guarantee, guarantee for credit enhancement, and letter of comfort. Power Finance also provides consultancy services in the areas of procurement of power by distribution licensees; renewable and non-conventional energy schemes; selection of developers for coal blocks; selection of EPC contractors; reform, restructuring, and regulatory aspects; capacity building and human resource development; and execution of ultra-mega power projects, and independent transmission projects. It serves state electricity boards, state power utilities, central power sector utilities, power departments, equipment manufacturers, private power sector utilities, joint sector power utilities, and other state departments engaged in the development of power projects. Power Finance began operation in 1986. It has its headquarters in New Delhi in India.
- Grenergy Renovables — Entwicklung von Photovoltaik und Speicher Projekten und Speicher Projekten mit Grenergy. Willkommen bei Grenergy
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 87
- Round size: Series A $5.3M–$26M; Series B $4.9M–$83M; Series C $5.8M–$48M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $113M in 2018
Portfolio highlights
- Vaximm — Vaximm is focused on developing active immunotherapies (vaccines) for patients suffering from cancer. Their initial product candidate VXM01 is targeting the tumor vasculature, which is essential for tumors to grow beyond microscopic size. Vaximm has shown impressive anti-tumor activity in various animal studies and will enter first human clinicaltrials in 2011.
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- Affimed — At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim toovercome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more...Investment focus
- Industry: Information Technology, Software, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 127
- Round size: Seed $219k–$7.7M; Series A $3.8M–$33M; Series B $3.8M–$71M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- OMMM — OMMM Operations Management Solutions is a software house that specializes in the digitization and automation of industrial planning.
- Cellbox Solutions — Cellbox Solutions is a young technology company that focuses on innovative logistic solutions for the global BioMed industry.
- Emergence Therapeutics — Emergence Therapeutics is a European biopharmaceutical company developing novel antibody-drug conjugates (ADC) to treat high-need cancers. Its lead program combines a highly specific antibody with optimized linker and payload technology to target Nectin-4 – an important target for a broad range of cancers which has been clinically validated as anADC target by enfortumab vedotin, now approved for the treatment of urothelial cancers by the US Food and Drug Administration. Emergence is also actively exploring opportunities to develop further first- or best-in-class ADCs driven by therapeutic need.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: Germany, France, Austria
Investor stats
- Total investments: 96
- Round size: Series A $2.2M–$40M; Series B $1.6M–$54M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $70M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 123
- Round size: Seed $1.3M–$7.3M; Pre-Seed $478k–$2.7M; Series A $6M–$18M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $23M in 2020
Portfolio highlights
- ThinkSono — ThinkSono Guidance enables any non-ultrasound trained healthcare professional to scan for blood clots (DVT). It reduces waiting times, negative DVT cases and can be used at the point of care.
- Univa Health — Eating disorders care for children, teens and adults. Support for parents and carers to strengthen recovery
- Bea Fertility — Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 149
- Round size: Seed $932k–$4.8M; Series A $1.9M–$15M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- In.hub — in.hub is a specialist in condition monitoring of machines, processes, and products, offering digitalisation options in the industrial environment. It connects legacy and modern systems, creates condition monitoring systems, and generates information for optimal planning and control.
- Packwise — Packwise is bringing Intermediate Bulk Containers (IBCs) to the Internet of Things. Their Packwise Smart Cap makes a container intelligent and allows for improved and automated packaging management and logistics. Millions of IBCs are being used by chemical, pharmaceutical and food companies every day. Their Packwise Smart Cap is narrow-band LPWANconnected and provides users with real-time information on the state and location of containers.Packwise develops ready-to-use web applications and can be integrated with existing in-house IT or software through web service API.Packwise GmbH is a German company based in the Silicon Saxony. Packwise is Europe’s pioneer in digital industrial packaging management (IBCs and drums).
- HandsOn Robotics —
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 194
- Round size: Series A $3.1M–$33M; Series B $7.7M–$55M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $222M in 2019
Portfolio highlights
- nyra health — myReha is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. myReha was founded in 2020 and was headquartered in Vienna, Austria.
- UiPath — Reinvent your workplace with the leading robotic process automation platform and learn how UiPath can help your company become a fully automated enterprise.
- UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 74
- Round size: Seed $823k–$6.1M; Series A $2.7M–$14M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Seqstant — Seqstant offers the LiveGene platform for real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
- k2-mobility — Operators of heavy vehicle fleets are facing one of the most significant transformational challenges by switching to electric vehicles. The additional time for battery charging, the limited vehicle range as well as diligent planning of energy consumption need to be dynamically integrated and accounted for in their daily operations. K2Mobility's software PANION has a real-time connection to the transport and tour plans, to the vehicles, the chargers and the grid and is planning and optimizing charging for operational excellence, energy cost and Total Cost of Ownership.
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 230
- Round size: Seed $1.3M–$9M; Series A $4M–$22M; Series B $8M–$52M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $135M in 2021
Portfolio highlights
- Ledgy — Digitize your cap table, automate equity plans and simplify compliance. Find out how leading companies use Ledgy to empower their employees and engage investors.
- Ververica — Ververica is the company founded by the original creators of Apache Flink, enabling companies to run in real-time with Ververica Platform.
- Seven Senders — Excellent international delivery is a competitive advantage. Connect with Seven Senders and benefit. Find out more now!
We support exceptional founders in building market leading digital companies.
Show more...Investment focus
- Industry: E-Commerce, Software, Internet
- Stage:Series A, Seed, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 436
- Round size: Seed $1.5M–$12M; Series A $3.3M–$34M; Series B $7.5M–$80M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $834M in 2023
Portfolio highlights
- Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
- Exein — The firmware security software and middleware can be injected like a vaccine in the hardware and aims to defend it from inside, working directly into the firmware at a lower level.
- Acurast — Acurast Decentralized Serverless Cloud, leveraging the multipliers of mobile phones for compute.
Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, France
Investor stats
- Total investments: 39
- Round size: Seed $1M–$9.5M; Pre-Seed $1.9M–$4M; Series A $9M–$33M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $102M in 2020
Portfolio highlights
- Apheris — Superior drug discovery models through federated data networks
- Entyre — Entyre's health care specialists consult home-staying patients and their relatives towards a better recovery.
- Spotlight Medical — We create personalized clinical tests to optimize treatment selection for every patient on earth.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Australia, United States
Investor stats
- Total investments: 163
- Round size: Seed $1.6M–$10M; Pre-Seed $549k–$3.8M; Series A $9.5M–$44M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Eden Brew — Eden Brew is a ground-breaking new way to enjoy dairy products sustainably and nutritiously.
- Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit
- InSpacePropulsion Technologies — Cost-effective, robust, and quickly available propulsion solutions, based on 10+ years of R&D and 40 years of combined experience in space propulsion.
Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 213
- Round size: Seed $1M–$4.6M; Series A $2.2M–$9M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $33M in 2022
Portfolio highlights
- SkillYoga — Get a personal yoga training plan based on your goals and experience. Functional, down-to-earth yoga training: anytime, anywhere. Become a better athlete today!
- Likeminded — Likeminded developed a digital platform for mental health that gives people fast, low-threshold access to psychological support.
- BOOST Thyroid — Hashimoto's and hypothyroid app. Empowering people with an underactive thyroid to take full control of their own health. Learn more about underactive thyroid on BOOST's website, with articles including the latest research and advice on thyroid health and autoimmunity.
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, Poland
Investor stats
- Total investments: 84
- Round size: Seed $110k–$6.3M; Pre-Seed $770k–$2.9M; Series A $2.4M–$14M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
- Qualifyze — Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
- Akhetonics — Creating the first all-optical RISC Processor
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more...Investment focus
- Industry: Financial Services, Software, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 341
- Round size: Seed $1.5M–$11M; Pre-Seed $549k–$4.5M; Series A $3.7M–$33M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $140M in 2024
Portfolio highlights
- Solarize — Solarize provides SaaS for energy production, distribution and billing for commercial microgrids.
- D2X Group — Trade digital asset options and futures on the EU-regulated market infrastructure for institutions.
- Lightbase — Plan, align, and ship complex projects faster. Lightbase maps your architecture across services and hands agents the full context to make safe, coordinated changes.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Software, Health Care, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 199
- Round size: Seed $1.2M–$9.1M; Pre-Seed $850k–$3.8M; Series A $5.3M–$32M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Clue — Track your menstrual cycle with the Clue app, a women-led period and cycle tracker. Get science-based insights, predictions, and personalized tracking.
- bonify — Bonify, a Berlin based FinTech-Start-up, enables customers to benefit from their credit scoring and financial data. The company gives customers free and easy access to their credit score and let them upload additional relevant data. Then, it offers tools and personalized recommendations to help optimize the customer’s financial situation.Foundedin 2015 by key executives of McKinsey and Zalando, bonify has received significant funding from internationally leading VCs and successful entrepreneurs.
- tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 63
- Round size: Seed $461k–$7M; Series A $1.1M–$18M
- Lead/follow: 62% lead, 38% follow
Portfolio highlights
- Altavo — Altavo operates as a medical device startup. Altavo harness the power of machine learning and state-of-the-art sensor technology to improve the lives of people who have lost their voice.
- Leapter — Leapter is the trust engine for AI agents. Build logic tools for AI Agents and de-risk your AI workflows with visual, executable blueprints for deterministic decisions.
- Influnate — Influnate is a tool that allows you to send and receive money via social media. Influnate enables users in social networks to “send and receive money easily, securely and quickly”. This can be done with a comment, a link, or via the Influnate web application. “Redirects to paid websites are a thing of the past,” said the startup.
Investing early in Europe's most passionate founders.
Show more...Investment focus
- Industry: Health Care, Software, Financial Services
- Stage:Seed, Series A
- Geography: Germany, Austria, United Kingdom
Investor stats
- Total investments: 73
- Round size: Seed $1M–$7.7M; Series A $3.8M–$31M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Enote — Enote is an innovative digital sheet music app, described by The Guardian as “a gamechanger for musicians". The company has developed a world-leading AI-technology, that allows to digitize paper sheet music into fully digital musical scores. This brings long awaited innovation to over 200 million musicians around the world, making sheet musicmore affordable, convenient and interactive than ever.
- Buynomics — buynomics is the leading solution to optimize your product portfolio. Our clients use buynomics to optimize pricing, promotions, & portfolio architecture.
- Broken String Biosciences — The next generation of genome-wide on- and off-target analysis in your own hands. Our INDUCE-seq platform provides precise off-target detection and genome-wide insights.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We back ambitious HealthTech founders solving complex healthcare challenges. We provide capital, deep sector expertise, and hands-on support to build global champions.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Poland, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $2.6M–$5.6M; Pre-Seed $764k–$2.5M; Series A $10M–$48M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely still investing — raised $70M in 2022
Portfolio highlights
- Biorce — Biorce is an innovating HealthAI startup committed to transforming drug development through the use of artificial intelligence.
- Clare&me — Clare is your virtual coach which calls you whenever you want and wherever you are. Stigma free phone calls and messaging based on cognitive- behavioral therapy. clare&me supports you on your self-help journey to better sleep, less worry and more self-confidence.
- Holi — Holi is a digital metabolic wellness clinic.It helps to treat Obesity, insulin resistance, type 2 diabetes, and heart diseases.
Maximilian Tayenthal is co-founder and co-CEO of N26. Together with his business partner and friend Valentin Stalf, he built one of the first and now fastest-growing mobile banks in Europe. Their vision was to create a retail bank that's flexible, transparent and speaks to today's digital lifestyles. Previously, Max worked in a varietyof consulting and financial roles at leading professional services firms, including CMS and Booz & Company. Max holds bachelor’s and master’s degrees in economics and business administration from the University of Vienna. He also has a master’s degree in economics from the Community of European Management Schools, as well as a law degree form the University of Vienna. Max is a CFA charterholder. While Max is based in Berlin, he always makes time for his passion outside of personal finance: skiing in the mountains of Austria and Switzerland.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United Kingdom, Spain
Investor stats
- Total investments: 26
- Round size: Seed $1.1M–$7M; Pre-Seed $202k–$3.3M; Series A $11M–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Terra One — Terra One engages in the development and operation of large-scale battery storage systems.
- Calibre — Calibre uses causal AI in conjunction with clinical expertise to help people understand what is truly influencing their health and how to modify it.
- Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.
KHAN Technology Transfer Fund operates as an investment firm.
Show more...Investment focus
- Industry: Biotechnology, Medical, Biopharma
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, Austria, Luxembourg
Investor stats
- Total investments: 11
- Round size: Seed $259k–$10M; Series A $5.5M–$11M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- KyDo Therapeutics — KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
Backing early-stage startups that drive positive impact for people and planet
Show more...Investment focus
- Industry: E-Commerce, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, Denmark
Investor stats
- Total investments: 88
- Round size: Seed $3.3M–$11M; Series A $5.5M–$33M; Series B $10M–$88M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Rebike Mobility — rebike1 purchases new E-Bikes from Top manufactures and brands like Winora/Haibike, Husqvarna, Flyer, KTM, Orbea. After renting the E-Bikes to businesses and consumers, the fully refurbished E-Bikes are sold with a 2 yr. warranty on rebike1. rebike1 also purchases used stock of E-Bikes from rental stations and retailers and sell them fullyrefurbished to consumers. In Oberstdorf, a Top tourist location south of Munich, rebike1 operates the largest E-Bike rental station in the area. Under the brand ebike1verleih, the rental business is expanding within tourist areas in partnership with local bike-shops. rebike1 GmbH was founded 2018 and has 18 employees today.
- Farmless — A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks.
- Ruuky — Pockid GmbH offers a bank account with virtual and physical debit Mastercard.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 174
- Round size: Series A $6.9M–$77M; Series B $12M–$103M; Series C $12M–$165M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $266M in 2023
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Neuros Medical — Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine.
- Simplify Medical — Simplify Medical designs, develops, and manufactures cervical artificial discs for use in the spine. It offers an MRI compatible motion preserving artificial cervical disc that is used to treat single level symptomatic cervical disc disease.The company provides its products for skeletally mature patients for reconstruction of the disc at onelevel from C3-C7 following single-level discectomy for intractable radiculopathy, such as arm pain or a neurological deficit.Simplify Medical was founded in 2015 and is based in Mountain View, California.
Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Austria, Switzerland
Investor stats
- Total investments: 77
- Round size: Seed $1.1M–$5.8M; Pre-Seed $603k–$3.9M; Series A $2.7M–$20M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Covalo — Covalo™ is disrupting how formulation-driven products are developed in the 3 trillion euro consumer goods industry so brands can reduce time to market by scouting ingredients and packaging, collaborating on projects, and purchasing -- all from one place. . Today it's one of the largest beauty ingredient search platforms that connects beautybrands with suppliers of ingredients, packaging, and services such as contract manufacturing, formulation, regulatory, compliance and testing. It also arms suppliers with the tools and real-time industry insights needed to effectively market products. Covalo launched in 2021 and is based in Switzerland.
- Cashlink — The financial technology start-up (Fintech) Cashlink has developed one of Europe's leading Tokenization-as-a-Service solutions. A modular, technological infrastructure enables the legally compliant issuance and management of digital securities for banks and investment platforms as an all-in-one solution. Compared to a traditional security,tokenized financial instruments create significant cost reductions and opportunities for opening up new markets and products, giving issuing companies, banks and investment platforms a sustainable competitive advantage. Renowned companies such as the Frankfurt securities specialist Bankhaus Scheich are already successfully using the Cashlink solution today. Cashlink is an official partner of Deutsche Börse Venture Network and completes its comprehensive range of digital securities by cooperating with experienced and specialized partners such as the globally operating law firm Ashurst. Renowned European investment companies such as the listed FinLab AG and the seed + speed-VC of the Maschmeyer Group are invested in the Fintech. As a founding member of the European forum "International Association for Trusted Blockchain Applications" (INATBA), the Hesse regional group of the Blockchain Bundesverband and the International Token Standardization Association (ITSA), Cashlink is already shaping tomorrow's capital market today.
- OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
Feliks Eyser is the founding partner of JETPACK.
Show more...Investment focus
- Industry: Software, E-Learning, Medical
- Stage:Seed, Series A
- Geography: Germany
Investor stats
- Total investments: 14
- Round size: Seed $3.2M–$5M; Series A $6.4M–$27M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Truckoo — Sell to a global audience, receive bindings bids. Buyers can be assured that all vehicles were inspected by us. We organize papers and transport.
- Wisefood — Wisefood develops new patented recipes and also manufacturing methods to replace disposable plastic tableware with edible variants
- Wunderflats — Find furnished apartments for temporary or longer stays with 1 click on Wunderflats. Verified and complete online booking for relocation, business, or students.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Springboard Health Angels is a Berlin based Angel group to invest in early stage Digital Health startups
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Pre-Seed
- Geography: Germany, United States, Sweden
Investor stats
- Total investments: 17
- Lead/follow: no public data
Portfolio highlights
- deepeye — deepeye® is a precision medicine platform for retinal diseases. It enables ophthalmologists to provide individual therapy to patients suffering from prevalent eye diseases like Age-related Macular Degeneration (AMD) or other retinal diseases which affect 12% of the EU+US population, thus preventing the causes of more than 66% of blindness'.
- Vivalyx — Vivalyx Omnisol will be a process- and cost-effective one-stop solution for all preservation applications, allowing NMP without the use of blood or human products.
- Cellbyte — AI Agents for Pricing and Market Access Teams in the Pharmaceutical Industry.
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Series B
- Geography: Germany, Italy, United States
Investor stats
- Total investments: 117
- Round size: Series A $428k–$23M; Series B $732k–$21M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- EcoG — EcoG connects and enables monetizing charging infrastructure with an API-software platform. EcoG is the first cloud-based platform to enable shared revenue streams and value-added services in fast charging. With EcoG a personalized and customized EV fast charging experience is easy to implement and operate.
- IDnow — IDnow provides advanced machine-learning technology for its Identity-as-a-Service platform that can verify identities in real time. The company's solutions guarantee legal security throughout Europe and the highest level of data security. The company provides a legally secure solution without additional hardware in the area of videoidentification of customers and electronic signatures.The company's offer is directed at all business customers who would like to provide customer identification and contract conclusion online, such as banks, telecommunications companies, Fintechs, etc. Its customer portfolio includes renowned firms such as Commerzbank, UBS, Sixt neuwagen, Telefónica, and N26.IDnow was founded on 2014 and is headquartered in Munich, Germany.
- DRACOON GmbH — Every company faces the challenge of storing, managing and sharing data digitally and securely. With our highly secure and platform-independent enterprise file service, we offer our customers maximum flexibility - and at the same time a 100% GDPR-compliant solution. This gives the world back its sovereignty over its data. Our solution DRACOON isthe market leader in the field of enterprise filesharing in the German-speaking area. We live, act and develop according to the principle "Privacy by Design". Our service has already been named as a "Leader" by independent top analysts such as ISG. But also various certificates and seals such as ISO27001 and EuroPriSe rattest DRACOON’s highest security standards. With our service we integrate ourselves deeply into the company processes and thus deliver a maximum protected cocoon for your data - and every connected application. These companies already trust DRACOON: KfW, Rossmann, Helios Kliniken, Rödl & Partner, ElringKlinger, EbnerStolz, DATEV, Nürnberger Versicherung, Thyssen Steel, Deutsche Telekom, Hutchison, Bechtle and many more.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, Israel
Investor stats
- Total investments: 17
- Round size: Seed $3M–$6.3M; Series A $10M–$20M; Series B $7.2M–$33M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- AppLike — AppLike develops apps for all mobile devices and provides mobile advertising, app recommendation, and innovative B2B solutions. The company was founded in 2015 and is headquartered in Hamburg, Germany.
- Teton — The future of contactless patient monitoring to prevent exacerbation
- Birches Health — Discover Birches Health, a specialized provider of online therapy for gambling addiction and other compulsive behaviors. Start recovery today with expert online counseling covered by insurance.
UNIQA Ventures GmbH is the Venture Capital arm of UNIQA Insurance Group AG, a leading insurance carrier in Central & Eastern Europe and a pioneer in Corporate-backed Venture Capital in Austria and CEE. Based in Vienna, Austria, the firm is investing in outstanding business models driven by strong teams and a clear vision to shape the future ofkey industries. Investment areas are the future of Health, Mobility, Intelligent Home and FinTech/InsurTech as well as enabling technologies such as IoT, Blockchain, ML/AI.
Show more...Investment focus
- Industry: FinTech, Insurance, Health Care
- Stage:Series A, Seed, Series B
- Geography: Austria, Germany, United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $439k–$5.3M; Series A $5M–$13M; Series B $15M–$125M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- ifeel — Ifeel is the emotional well-being platform for modern organizations. Ifeel is a unique workplace mental health platform for companies.
- GoUrban — goUrban offers mobility solutions for sharing operators and B2B fleet management. The way of transportation and mobility is changing rapidly. For operating smarter and using the opportunities of the sharing economy we provide you our fleet management OS.
- doctorly — doctorly is a digital medical infrastructure platform. We have a regulated, cloud powered, fully centralised, practice management platform for doctors, a fully connected health app for patients, and an integration platform for the wider industry to natively connect their tools & workflows directly with our doctors & patients.We are backedby amazing investors and driven by a desire to make positive and meaningful changes to the healthcare industry internationally.
Global Asset Fund is a private equity firm based in Germany that finances early and later stage venture investments. The fund enables the development of products and technologies that address a growing market of tomorrow.
Show more...Investment focus
- Industry: Medical, Therapeutics, Biotechnology
- Stage:Series A, Series B
- Geography: Germany
Investor stats
- Total investments: 8
- Round size: Series A $1M–$1.9M; Series B $1.6M–$2.9M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Siltectra — SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials.
- Isarna Therapeutics — Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.
Show more...Investment focus
- Industry: Medical, Health Care, Shopping
- Stage:Seed, Series A, Series C
- Geography: Germany, United States
Investor stats
- Total investments: 7
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
- PERCEPTEC — PERCEPTEC is an application-oriented think tank with the aim of accelerating the process of modernization and digitalization of the optometric and ophthalmological sector.
- DeepEn — DeepEn is a research transfer start-up from Leibniz Institute of Photonic Technologies. It focus on the development of solutions in the field of fibrephotonics, biophotonics and bioimaging.
Super Angels is a investment firm.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed
- Geography: Germany, United States, India
Investor stats
- Total investments: 29
- Round size: Seed $357k–$3.5M; Pre-Seed $250k–$3.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Arctis AI — Arctis AI develops an AI platform to manage building contracts. It transforms difficult papers into useful insights for project teams.
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- HandsOn Robotics —
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 528
- Round size: Seed $823k–$8M; Pre-Seed $549k–$3.8M; Series A $3.7M–$38M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $384M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- MinersAI — Unlock valuable insights from intricate geological data with Miners AI. Our AI-driven platform empowers exploration teams to make informed decisions and optimize mining operations.
- Primer — Primer is the first open automation platform for payments, enabling you to build end-to-end payment flows with no code, and a checkout developers love.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 187
- Round size: Series A $16M–$176M; Series B $15M–$155M; Series C $19M–$113M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
- Noema Pharma — DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 81
- Round size: Seed $658k–$3M; Grant $80k–$165k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
- Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
- DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Playground Global is an early-stage venture capital firm backing technical and scientific founders with deep engineering expertise, a collaborative environment, and a first-hand understanding of the intricacies of deep tech. Established in 2015 and headquartered in Palo Alto, CA, Playground’s mission is to transform ambitious ideas into impactfulbusinesses that benefit humanity and the planet. We invest in areas that span across next gen compute automation, energy transition and engineered biology. Playground has been an early – and frequently first investor – in companies that include PsiQuantum, Relativity Space, Ultima Genomics, MosaicML (acq. by Databricks), d-Matrix, and Strand Therapeutics.
Show more...Investment focus
- Industry: Software, Robotics, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Italy
Investor stats
- Total investments: 137
- Round size: Seed $2.2M–$20M; Series A $7M–$35M; Series B $20M–$153M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $410M in 2023
Portfolio highlights
- Velo3D — Design, print and produce critical metal parts with Velo3D's advanced laser powder bed fusion technology. Trusted by aerospace, defense, and energy leaders.
- Saltbox — Saltbox makes the hardest parts of running an ecommerce business simple. Explore our logistics and warehouse solutions growing eCommerce companies
- Strand Therapeutics — Clinical-stage biotech developing breakthrough mRNA therapeutics with targeted delivery systems for solid tumors, autoimmune diseases, and blood cancers.
Capacura is reinventing the venture capital market so that more start-ups get access to capital, knowledge, processes and solutions.
Show more...Investment focus
- Industry: Health Care, Recycling, Medical
- Stage:Seed, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 22
- Round size: Seed $250k–$1.6M; Pre-Seed $889k–$932k
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Pilzling — Bio-Pilze direkt aus deiner Stadt.
- hey circle — Hey Circle is a manufacturer of reusable shipping packaging. Hey Circle products include foldable, weather and dirt-resistant shipping bags and reused shipping boxes with theft protection and branding possibilities for brands, offering customers with a sustainable solution that is simple to use for packers and customers.
- Circolution — circolution creates a solution that makes a contribution to reducing the waste problem. Our customers and partner companies ensure that bottling, logistics, return, cleaning and inspection processes are safe and automated.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 98
- Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
- Centauri Therapeutics — At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.
WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.
Show more...Investment focus
- Industry: Software, Internet, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States, France
Investor stats
- Total investments: 53
- Round size: Seed $1M–$12M; Series A $3M–$7M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Notch — Boost your deal win rates and customer onboarding with Notch. Create tailored buyer experiences, structured action plans, and gain valuable insights. Try our demo today.
- Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
- ClimateChoice — The software platform for decarbonizing companies and their supply chains.
Diana zur Löwen
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Pre-Seed, Seed, Debt Financing
- Geography: Germany, Switzerland
Investor stats
- Total investments: 9
- Round size: Seed $3.6M–$4.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LAP Coffee — LAP Coffee is a community-driven specialty coffee brand.
- Calvin Risk — We help companies manage the risks of their AI algorithms!
- Penzilla — At Penzilla, we believe it's time to make corporate pension provision the way it really should be - simple. That's why we offer a solution that helps everyone get the maximum benefit from corporate pension options. Most importantly, we enable every employer to achieve true corporate social responsibility with 100% compliance and everyemployee to receive a fair pension. This is how corporate pension provision works with Penzilla: Let's "Simply Provision" together.
Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries
Show more...Investment focus
- Industry: Software, Medical, Health Care
- Stage:Seed, Series A, Series B
- Geography: Germany, Finland, United States
Investor stats
- Total investments: 23
- Round size: Seed $1.1M–$3.3M; Series A $3M–$3.3M; Series B $1.1M–$3.3M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Semorai — The SEMORAI Engineering AI Suite is your App Store for AI agents for reliable support in demanding mechanical engineering. Connect comprehensive engineering knowledge with your company know-how to accelerate your processes through AI to an unprecedented degree.
- Doinstruct — Doinstruct offers mobile training solution for frontline workers.
- traplinked — Digitale Fallensysteme - Endlich wissen, was los ist! Mit den traplinked Sensormodulen JERRY und TOM erhalten Sie in Echtzeit ein digitales Abbild Ihrer Kontrollpunkte.
Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 110
- Round size: Seed $1.3M–$6.5M; Series A $3.7M–$24M; Series B $3.3M–$41M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $117M in 2020
Portfolio highlights
- Altoida — Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),and artificial intelligence (AI).Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.
- SMART VALOR — SMART VALOR is a secure investment platform offering easy buy and sell of cryptocurrencies like Bitcoin, Ethereum, Dash and more. Trade and store digital assets.
- JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
Verena Pausder
Show more...Investment focus
- Industry: Food and Beverage, E-Learning, EdTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $1.8M–$12M; Pre-Seed $1k–$2.6M; Series A $7.9M–$18M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Karri — KARRI is a data and GPS enabled, screen-free device for easy communication between you and your kids. A KARRI for your child and a smartphone app for you - it's as simple as that.
- Knowunity — Knowunity is the digital learning platform with summaries, study notes, presentations, answers, and more in one app.
- Huzzle — Stop chasing jobs. Huzzle collects the best opportunities from student societies and companies and only shows you the relevant ones. Download Huzzle today!
Gloria primarily focuses on growth stage investments across all sectors in Europe and Australia. Prior to Index, Gloria worked at Technology Crossover Ventures, a Silicon Valley-based growth equity fund, evaluating investment opportunities in the DACH region and in software and fintech companies across Europe. Gloria started her career at MorganStanley where she advised technology and telco clients across Europe and the U.S. on financing rounds, IPOs and M&A transactions. Gloria graduated with a master’s degree in management from WHU – Otto Beisheim School of Management
Show more...Investment focus
- Industry: FinTech, Information Technology, B2B
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Sweden, Denmark
Investor stats
- Total investments: 13
- Round size: Seed $531k–$12M; Pre-Seed $549k–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Duna — Meet the modern platform that accelerates business onboarding, automates manual work and grows revenue.
- GsmBD.co — Rise helps you and your team stay organized and on track, with all your work in one place.
- Fullview — Fullview let's you instantly monitor, control and analyze user sessions for faster real time customer support. No downloads. Easy to integrate.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 26
- Round size: Series A $5.3M–$176M; Series B $5.3M–$45M; Series C $8M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $1.2B in 2022
Portfolio highlights
- Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
- iSTAR Medical — iSTAR Medical is a medtech company delivering breakthrough eye care solutions through minimally-invasive implants with bio-integration.
- HotSpot Therapeutics — HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspotstructures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Belgium, Germany, France
Investor stats
- Total investments: 60
- Round size: Series A $3.8M–$20M; Series B $4.4M–$27M; Series C $7M–$100M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Nutrium — Nutrium is the most up-to-date nutrition software for dietitians and nutritionists to manage their nutrition business with nutritional assessment, meal planning and progress tracking.
- ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Mario Götze is a professional footballer.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 57
- Lead/follow: no public data
Portfolio highlights
- Lemni — Set up custom Ai agents in minutes
- CROWN — CROWN is modernizing procurement negotiations through ethical eAuctions.
- welevel — Building games with attitude
Medical Investor funding in Germany at a glance
Stats across 450 deals from 597 investors.
Access all 597 investors in Germany Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 597 investors investing in Germany Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!